CatalYm to raise a €50m Series B financing round led by Vesalius Biocapital III Biotech Health services Manufacturing Investments 09 November 2020 Share:
Round value (USD): 59.05m Round investors: BioGeneration Ventures Forbion Capital Partners Novartis Venture Fund Vesalius Biocapital Partners Wachstumsfonds Bayern Company: CatalYm Industry: Biotech Health services Manufacturing
Eleva to get €60 million from Zukunftsfonds Heilbronn (ZFHN). Biotech Health services Investments 06 January 2021